Alan Tinmouth
About
In The Last Decade
Alan Tinmouth
163 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Biochemistry 3.3k
- Hematology 2.0k
- Critical Care and Intensive Care Medicine 1.5k
- Management of Technology and Innovation 1.0k
- Surgery 818
Countries citing papers authored by Alan Tinmouth
This map shows the geographic impact of Alan Tinmouth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Tinmouth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Tinmouth more than expected).
Fields of papers citing papers by Alan Tinmouth
This network shows the impact of papers produced by Alan Tinmouth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Tinmouth. The network helps show where Alan Tinmouth may publish in the future.
Co-authorship network of co-authors of Alan Tinmouth
This figure shows the co-authorship network connecting the top 25 collaborators of Alan Tinmouth. A scholar is included among the top collaborators of Alan Tinmouth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Tinmouth. Alan Tinmouth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 14 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | 10 | |
| 6 | Blood transfusion and the risk for infections in kidney transplant patients | 1 |
| 7 | 6 | |
| 8 | 23 | |
| 9 | 9 | |
| 10 | 4 | |
| 11 | 11 | |
| 12 | 1 | |
| 13 | 8 | |
| 14 | 7 | |
| 15 | 118 | |
| 16 | 56 | |
| 17 | 12 | |
| 18 | Appropriateness of the use of intravenous immune globulin before and after the introduction of a utilization control program. | 10 |
| 19 | 111 | |
| 20 | 53 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.